BioSpace News Archive

Retrophin, Inc. (NASDAQ:RTRX) today announced that it has been awarded the Peter Barron Stark Companies (PBS) Award for Workplace Excellence.

Retrophin, Inc. (NASDAQ:RTRX) today announced that the United States Patent and Trademark Office (USPTO) has issued a new patent covering the Company’s product candidate sparsentan which, in addition to being in Phase 3 clinical development for the treatment of focal segmental glomerulosclerosis (FSGS), is advancing to Phase 3 clinical development for the treatment of IgA nephropathy (IgAN).

Independence Blue Cross, LLC (“Independence”) is providing notice to certain members of a recent incident involving protected health information.

Eleven finalists will pitch their pediatric medical device innovation during the annual “Make Your Medical Device Pitch for Kids!” competition at the Sixth Annual Pediatric Device Innovation Symposium.

Retrophin, Inc. (NASDAQ:RTRX) today announced it will report second quarter 2018 financial results on Thursday, July 26, 2018 after the close of the U.S. financial markets.

Retrophin Inc. (NASDAQ:RTRX) today reported its second quarter 2018 financial results and provided a corporate update.

Retrophin, Inc. (NASDAQ: RTRX) today announced the pricing of its offering of $240 million aggregate principal amount of 2.50% convertible senior notes due 2025 (the “notes”) to be sold in an underwritten offering.

Total Education Solutions (TES), a leading provider of special education and therapeutic services, has expanded its online service offerings to meet the needs of schools, medical institutions, and families across the United States and abroad.

Amazon Web Services featured Angel MedFlight Worldwide Air Ambulance in a Partner Story outlining how the company is using technology to push healthcare forward.

Pharmacy First, a leading Pharmacy Services Administrative Organization (PSAO) supporting a network of independent pharmacies, has partnered with Medversant Technologies, LLC to collaboratively bring together a robust credentialing, compliance and monitoring program for Pharmacy First members.